Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | MAPT | P10636 | 2/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | CXCR3 | P49682 | 1/20 | 0.32 |
| ▸ | AHR | P35869 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25452287 | 1.00 | ALDH1A1 (0.33) | ALDH1A1MAPTKDM4EMEN1NPC1 | |
| SCHEMBL22788055 | 0.97 | ALDH1A1 (0.32) | ALDH1A1MAPTKDM4EMEN1NPC1 | |
| SCHEMBL22787927 | 0.97 | ALDH1A1 (0.32) | ALDH1A1MAPTKDM4EMEN1NPC1 | |
| SCHEMBL25451246 | 0.96 | ALDH1A1 (0.32) | ALDH1A1MAPTKDM4EMEN1NPC1 | |
| SCHEMBL22780451 | 0.94 | CXCR3 (0.33) | ALDH1A1MAPTLMNACXCR3 | |
| SCHEMBL22788024 | 0.94 | ALDH1A1 (0.31) | ALDH1A1MAPTLMNA | |
| SCHEMBL22780135 | 0.94 | ALDH1A1 (0.32) | ALDH1A1MAPTLMNACXCR3 | |
| SCHEMBL22779995 | 0.94 | ALDH1A1 (0.31) | ALDH1A1MAPTLMNA | |
| SCHEMBL25452282 | 0.93 | AHR (0.33) | ALDH1A1MAPTKDM4EMEN1NPC1 | |
| SCHEMBL25451937 | 0.93 | ALDH1A1 (0.36) | ALDH1A1MAPTKDM4EMEN1NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10985324-B2 | Nitrogen-containing compound, organic electroluminescent device and photoelectric conversion device | SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) | 2021-04-20 | — | — | US | disclosed |
| US-20200395544-A1 | Nitrogen-containing compound, organic electroluminescent device and photoelectric conversion device | SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) | 2020-12-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200395544-A1 | Nitrogen-containing compound, organic electroluminescent device and photoelectric conversion device | NOS1, NOM1, NUDC | ALDH1A1 1368/4885MAPT 1701/4885KDM4E 1571/4885 |
| US-10985324-B2 | Nitrogen-containing compound, organic electroluminescent device and photoelectric conversion device | NOS1, NOM1, NUDC | ALDH1A1 1368/4885MAPT 1701/4885KDM4E 1571/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.